Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
20:59:53 04/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+22.75% | -10.38% |
| Market Cap | 260M 229M 216M 196M 368M 24.97B 371M 2.59B 1B 12.74B 977M 955M 40.94B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 356M 313M 296M 269M 505M 34.19B 508M 3.55B 1.37B 17.45B 1.34B 1.31B 56.07B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.89x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +22.75% | ||
| Current month | +20.46% | ||
| 1 month | +8.12% | ||
| 3 months | +5.72% | ||
| 6 months | +0.04% | ||
| Current year | -10.38% |
| 1 week | 0.15 |  | 0.21 |
| 1 month | 0.15 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 0.94 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 31/05/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 07/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 31/12/1997 |
Linda Powers
CHM | Chairman | 71 | 16/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 31/03/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +22.75% | -19.61% | -76.44% | 260M | |
| -0.37% | -3.67% | +57.21% | +87.75% | 71.81B | |
| +1.11% | -0.21% | +39.66% | +85.32% | 60.06B | |
| +0.19% | +1.61% | +35.10% | +17.20% | 27.93B | |
| -0.14% | -2.75% | -14.13% | +356.79% | 25.7B | |
| +0.57% | +1.10% | +1.02% | -2.89% | 24.89B | |
| +0.74% | +1.62% | +26.42% | -7.66% | 20.92B | |
| -1.70% | +0.43% | +150.24% | +323.16% | 15.04B | |
| +0.36% | +2.01% | +49.51% | +160.70% | 14.46B | |
| +3.91% | -3.51% | -4.56% | +517.49% | 13.87B | |
| Average | +0.51% | -1.37% | +32.09% | +146.14% | 27.49B | |
| Weighted average by Cap. | +0.37% | -1.91% | +38.53% | +127.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.24M 32.38M 29.37M 55.16M 3.74B 55.48M 388M 150M 1.91B 146M 143M 6.13B |
| Net income | - | - |
| Net Debt | 96.08M 84.5M 79.91M 72.48M 136M 9.22B 137M 957M 370M 4.71B 361M 353M 15.12B | 125M 110M 104M 94.24M 177M 11.99B 178M 1.24B 480M 6.12B 469M 459M 19.67B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | US$0.1525 | -4.69% | 3,918,070 |
| 25/09/26 | US$0.1600 | +0.25% | 2,348,226 |
| 24/09/26 | US$0.1596 | -0.03% | 2,391,461 |
| 23/09/26 | US$0.1597 | -2.06% | 2,443,603 |
| 22/09/26 | US$0.1630 | -2.40% | 2,778,235 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1525USD
Average target price
1.000USD
Spread / Average Target
+555.74%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
